Cargando…
Understanding p53 tumour suppressor network
The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulation of several cellular functions, including cell cycle progression and cell death in response to genotoxic stress. In the recent years additional p53-mediated tumour suppression mechanisms have been d...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348811/ https://www.ncbi.nlm.nih.gov/pubmed/34362419 http://dx.doi.org/10.1186/s13062-021-00298-3 |
_version_ | 1783735433891414016 |
---|---|
author | Panatta, Emanuele Zampieri, Carlotta Melino, Gerry Amelio, Ivano |
author_facet | Panatta, Emanuele Zampieri, Carlotta Melino, Gerry Amelio, Ivano |
author_sort | Panatta, Emanuele |
collection | PubMed |
description | The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulation of several cellular functions, including cell cycle progression and cell death in response to genotoxic stress. In the recent years additional p53-mediated tumour suppression mechanisms have been described, questioning the contribution of its canonical pathway for tumour suppression. These include regulation of alternative cell death modalities (i.e. ferroptosis), cell metabolism and the emerging role in RNA stability. Here we briefly summarize our knowledge on p53 “canonical DNA damage response” and discuss the most relevant recent findings describing potential mechanistic explanation of p53-mediated tumour suppression. |
format | Online Article Text |
id | pubmed-8348811 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83488112021-08-09 Understanding p53 tumour suppressor network Panatta, Emanuele Zampieri, Carlotta Melino, Gerry Amelio, Ivano Biol Direct Opinion The mutation of TP53 gene affects half of all human cancers, resulting in impairment of the regulation of several cellular functions, including cell cycle progression and cell death in response to genotoxic stress. In the recent years additional p53-mediated tumour suppression mechanisms have been described, questioning the contribution of its canonical pathway for tumour suppression. These include regulation of alternative cell death modalities (i.e. ferroptosis), cell metabolism and the emerging role in RNA stability. Here we briefly summarize our knowledge on p53 “canonical DNA damage response” and discuss the most relevant recent findings describing potential mechanistic explanation of p53-mediated tumour suppression. BioMed Central 2021-08-06 /pmc/articles/PMC8348811/ /pubmed/34362419 http://dx.doi.org/10.1186/s13062-021-00298-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Opinion Panatta, Emanuele Zampieri, Carlotta Melino, Gerry Amelio, Ivano Understanding p53 tumour suppressor network |
title | Understanding p53 tumour suppressor network |
title_full | Understanding p53 tumour suppressor network |
title_fullStr | Understanding p53 tumour suppressor network |
title_full_unstemmed | Understanding p53 tumour suppressor network |
title_short | Understanding p53 tumour suppressor network |
title_sort | understanding p53 tumour suppressor network |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348811/ https://www.ncbi.nlm.nih.gov/pubmed/34362419 http://dx.doi.org/10.1186/s13062-021-00298-3 |
work_keys_str_mv | AT panattaemanuele understandingp53tumoursuppressornetwork AT zampiericarlotta understandingp53tumoursuppressornetwork AT melinogerry understandingp53tumoursuppressornetwork AT amelioivano understandingp53tumoursuppressornetwork |